Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.14
-0.03 (-0.58%)
Aug 14, 2025, 1:40 PM - Market open

Foghorn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
291262272267848721
Upgrade
Market Cap Growth
-17.65%-3.64%2.10%-68.56%17.59%-
Upgrade
Enterprise Value
1133459-54807894
Upgrade
Last Close Price
5.174.726.456.3822.8720.27
Upgrade
PS Ratio
13.4411.617.9713.87643.151677.72
Upgrade
PB Ratio
--5.76-3.532381.228.764.93
Upgrade
P/TBV Ratio
---2381.228.764.93
Upgrade
P/FCF Ratio
---1.39--
Upgrade
P/OCF Ratio
---1.38--
Upgrade
EV/Sales Ratio
4.691.511.74-612.132079.55
Upgrade
Debt / Equity Ratio
-0.31-0.82-0.58459.880.600.56
Upgrade
Debt / FCF Ratio
---0.27--
Upgrade
Asset Turnover
0.090.080.100.040.000.00
Upgrade
Quick Ratio
2.553.644.016.269.339.86
Upgrade
Current Ratio
2.623.734.116.379.4410.12
Upgrade
Return on Equity (ROE)
----224.54%-83.37%-95.05%
Upgrade
Return on Assets (ROA)
-20.70%-22.00%-19.53%-15.83%-16.24%-30.82%
Upgrade
Return on Capital (ROIC)
---691.63%-70.80%-32.84%-35.20%
Upgrade
Earnings Yield
-26.15%-33.01%-36.15%-40.83%-11.94%-9.54%
Upgrade
FCF Yield
-31.68%-38.61%-43.82%72.14%-6.31%-6.58%
Upgrade
Buyback Yield / Dilution
-41.03%-30.79%-0.92%-11.89%-236.49%-163.53%
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q